Covered recipient · General Payments record
ROLAND CHALIFOUX JR
Allopathic & Osteopathic Physicians Neurological Surgery
General Payments · PY2018–2024
$20,479.05
- Reported across 242 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,480.23 | 29 |
| Travel and Lodging | $734.93 | 5 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Curonix LLC | $1,157.23 | 12 |
| Medtronic, Inc. | $327.99 | 7 |
| SPINEFRONTIER, INC. | $186.12 | 2 |
| ABBVIE INC. | $118.25 | 1 |
| Abbott Laboratories | $94.75 | 1 |
| Collegium Pharmaceutical, Inc. | $79.94 | 4 |
| Lundbeck LLC | $60.38 | 1 |
| Averitas Pharma Inc. | $59.61 | 3 |
| Acerta Pharma LLC | $55.44 | 1 |
| Amgen Inc. | $54.16 | 1 |
| Bioventus LLC | $21.29 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (34)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $94.75 | 03/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125214119 | CMS |
| ABBVIE INC. | $118.25 | 10/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103435772 | CMS |
| Amgen Inc. | $54.16 | 04/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115489080 | CMS |
| AstraZeneca Pharmaceuticals LP | $55.44 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105551136 | CMS |
| Averitas Pharma Inc. | $17.86 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133420808 | CMS |
| Averitas Pharma Inc. | $18.65 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133420812 | CMS |
| Averitas Pharma Inc. | $23.10 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133420816 | CMS |
| Bioventus LLC | $21.29 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137437971 | CMS |
| Collegium Pharmaceutical, Inc. | $22.15 | 02/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135217137 | CMS |
| Collegium Pharmaceutical, Inc. | $21.44 | 08/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135285257 | CMS |
| Collegium Pharmaceutical, Inc. | $22.44 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135328499 | CMS |
| Collegium Pharmaceutical, Inc. | $13.91 | 12/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135335499 | CMS |
| Curonix LLC | $265.32 | 01/04/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1132906048 | CMS |
| Curonix LLC | $4.51 | 01/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132906050 | CMS |
| Curonix LLC | $74.24 | 01/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132906052 | CMS |
| Curonix LLC | $178.22 | 01/06/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1132906054 | CMS |
| Curonix LLC | $222.08 | 01/06/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1132906056 | CMS |
| Curonix LLC | $58.48 | 01/06/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1132906058 | CMS |
| Curonix LLC | $13.13 | 01/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132906060 | CMS |
| Curonix LLC | $10.83 | 01/06/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1132906062 | CMS |
| Curonix LLC | $26.25 | 02/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132906064 | CMS |
| Curonix LLC | $97.95 | 04/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132906066 | CMS |
| Curonix LLC | $102.41 | 04/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132906070 | CMS |
| Curonix LLC | $103.81 | 04/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132906074 | CMS |
| Lundbeck LLC | $60.38 | 11/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145903648 | CMS |
| Medtronic, Inc. | $14.59 | 01/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119449285 | CMS |
| Medtronic, Inc. | $20.58 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119449287 | CMS |
| Medtronic, Inc. | $142.42 | 03/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119449289 | CMS |
| Medtronic, Inc. | $102.15 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119449291 | CMS |
| Medtronic, Inc. | $6.46 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119449293 | CMS |
| Medtronic, Inc. | $18.24 | 08/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119449295 | CMS |
| Medtronic, Inc. | $23.55 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119449297 | CMS |
| SPINEFRONTIER, INC. | $79.50 | 04/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153800189 | CMS |
| SPINEFRONTIER, INC. | $106.62 | 06/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153800111 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.